(Q33398747)

26 July 2017

Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study (English)

1 reference

26 July 2017

Clostridium difficile

0 references

1 reference

Daniel M Musher

1

1 reference

26 July 2017

Nancy Logan

2

1 reference

26 July 2017

Adam M Bressler

3

1 reference

26 July 2017

David P Johnson

4

1 reference

26 July 2017

Jean-François Rossignol

5

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

Clinical Infectious Diseases

26 July 2017

1 reference

26 July 2017

48

1 reference

26 July 2017

4

1 reference

26 July 2017

e41-6

1 reference

A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use.

26 July 2017

1 reference

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

21 January 2018

1 reference

Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005

21 January 2018

1 reference

Treatment of Clostridium difficile-associated disease: old therapies and new strategies

21 January 2018

1 reference

Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole

21 January 2018

1 reference

Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada

21 January 2018

1 reference

A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity

21 January 2018

1 reference

Vancomycin for the treatment of Clostridium difficile Infection: for whom is this expensive bullet really magic?

21 January 2018

1 reference

Treatment of Clostridium difficile infection.

21 January 2018

1 reference

Nitazoxanide: a new broad spectrum antiparasitic agent

21 January 2018

1 reference

Nitazoxanide for the treatment of Clostridium difficile colitis

21 January 2018

1 reference

Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide

21 January 2018

1 reference

In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004

21 January 2018

1 reference

Nitazoxanide: clinical studies of a broad-spectrum anti-infective agent

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/596552

1 reference

26 July 2017

1 reference